Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy – A multicenter cohort study - Bolm, L; Ohrner, K; Nappo, G (Pancreatology, 2020)
et al.